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Abstract
Polycomb Repressive Complex 2 (PRC2) catalyzes histone H3 lysine 27 tri-methylation (H3K27me3), an epigenetic
modification associated with gene repression. H3K27me3 is enriched at the promoters of a large cohort of developmental
genes in embryonic stem cells (ESCs). Loss of H3K27me3 leads to a failure of ESCs to properly differentiate, making it difficult
to determine the precise roles of PRC2 during lineage commitment. Moreover, while studies suggest that PRC2 prevents
DNA methylation, how these two epigenetic regulators coordinate to regulate lineage programs is poorly understood.
Using several PRC2 mutant ESC lines that maintain varying levels of H3K27me3, we found that partial maintenance of
H3K27me3 allowed for proper temporal activation of lineage genes during directed differentiation of ESCs to spinal motor
neurons (SMNs). In contrast, genes that function to specify other lineages failed to be repressed in these cells, suggesting
that PRC2 is also necessary for lineage fidelity. We also found that loss of H3K27me3 leads to a modest gain in DNA
methylation at PRC2 target regions in both ESCs and in SMNs. Our study demonstrates a critical role for PRC2 in
safeguarding lineage decisions and in protecting genes against inappropriate DNA methylation.
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Background
Regulation of chromatin structure is a key mechanism for
controlling gene expression patterns in response to developmental
and environmental cues. Polycomb Group (PcG) proteins play
crucial roles in epigenetic gene regulation in all metazoans by
modifying chromatin structure. PcG proteins function in a variety
of biological pathways including lineage commitment in mammals
[1–3]. Ablation of any core Polycomb Repressive Complex 2
(PRC2) component, including SUZ12, EED, or EZH2 leads to
embryonic lethality in mice during gastrulation, a developmental
time point when complex gene expression patterns are established
in the embryo [4–6]. PRC2 catalyzes tri-methylation of histone
H3 lysine 27 (H3K27me3), a modification associated with
transcriptional repression [7]. In Drosophila, mutations in histone
H3 that disrupt K27 methylation lead to phenotypes similar to
Polycomb mutants, indicating that H3K27me3 is a crucial
mediator of PRC2 function [8]. These data suggest that PRC2
is necessary for regulation of cell fate, yet its role in this process is
poorly understood.
Embryonic stem cells (ESCs) have the potential to become any
type of cell in the adult organism. This property underpins their
utility as a model system to study the mechanisms that drive cell
differentiation. In ESCs, PRC2 occupies a large cohort of
developmental genes to regulate lineage commitment [9–12]. At
these genes, H3K27me3 is largely enriched at transcription start
sites (TSSs) along with H3K4me3, an activating histone mark
associated with Trithorax group (TrxG) proteins [13–15]. These
‘‘bivalent’’ promoters are thought to poise genes for later
activation during lineage commitment. Bivalent genes in ESCs
largely resolve to either an active (H3K4me3 only) or repressed
(H3K27me3 only) state during differentiation [14], suggesting that
H3K27me3 is critical for both gene repression and for the proper
activation of developmental programs during lineage commit-
ment. However, we lack a detailed understanding of how
disruption of PRC2 activity in ESCs affects lineage commitment
because loss of H3K27me3 leads to a global failure of these cells to
properly differentiate.
Emerging evidence suggests crosstalk between PRC2 and the
DNA methylation machinery is necessary to ensure proper
development. For example, H3K27me3 and DNA methylation
are largely exclusive at promoters across human tissues [16] and
DNA hypomethylation of bivalent promoters in ESCs appears
necessary for maintaining developmental plasticity [17]. Recent
studies using Me-DIP showed that loss of H3K27me3 in Eednull
ESCs leads to changes in DNA methylation levels; however, the
resolution of this assay was not sufficient to test a direct
relationship between these two regulatory pathways [18]. Notably,
PRC2 target genes tend to be DNA hypomethylated in cancer
cells that show high levels of Polycomb components such as Ezh2
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[19,20]. While these data suggest that at least in some cases
Polycomb activity antagonizes DNA methylation [21], we know
little about how their activities are coordinated during lineage
commitment. Thus, knowledge of how PRC2 regulates lineage
commitment will be critical for understanding its roles in
development and how faulty regulation leads to diseases such as
cancer.
We investigated the role of PRC2 in regulating gene expression
patterns during lineage commitment by analyzing several mutant
ESC lines that maintain varying levels of H3K27me3. In
particular, we found that a previously described Suz12 gene trap
(Suz12GT) ESC line [22] maintained intermediate levels of
H3K27me3 and was able to undergo directed differentiation
in vitro, albeit less efficiently compared to wild-type cells [23].
This result is in contrast to Suz12 truncation (Suz12D) or Eed
point mutant (Eednull) ESCs that show near-complete loss of the
mark and an inability to differentiate [10,24]. Using this set of
genetic tools, we demonstrate that proper H3K27me3 levels are
necessary for both activation of lineage programs and for
repression of alternate pathways to maintain lineage fidelity
during directed differentiation of ESCs toward spinal motor
neurons (SMNs). We next analyzed changes in DNA methylation
levels in Suz12GT cells during SMN differentiation at nucleotide
resolution and found that loss of H3K27me3 directly led to a
modest gain in DNA methylation at PRC2 target regions. While
disruption of normal DNA methylation levels did not lead to
further changes in expression of PRC2 targets in Suz12GT cells, we
propose that a low-level gain of DNA methylation at promoters
may lead to further epigenetic instability. Thus, our findings
indicate that PRC2 activity is necessary to maintain cell fate
plasticity and lineage fidelity during differentiation, and may
safeguard developmental genes against more permanent repres-
sion.
Results
PRC2 mutant ESC lines maintain varying levels of
H3K27me3
PRC2 catalyzes H3K27me3, and its recruitment to a large
cohort of developmental genes in ESCs suggests a critical role for
PRC2 in regulating lineage commitment [9,10,25]. Because PRC2
mutant ESCs are unable to undergo proper directed differentia-
tion, how PRC2 regulates gene expression patterns during lineage
commitment is poorly understood. Our recent work found that a
Suz12 genetrap ESC line that creates a SUZ12-b-galactosidase
fusion (denoted here as Suz12GT) (Figure 1A and S1A–B) [22]
maintained H3K27me3, albeit at lower levels compared to wild-
type cells [23]. Importantly, while these cells exhibit impaired
differentiation, H3K27me3 levels in Suz12GT cells can be rescued
by exogenous expression of wild-type Suz12 indicating that the
activity of the complex can be restored to normal levels [26]. By
comparison, another Suz12 mutant ESC line (denoted here as
Suz12D) generated by truncation of SUZ12 (Figure 1A and S1A–
B) and an ESC line that harbors a point mutation in Eed (denoted
Eednull) exhibit near complete loss of bulk H3K27me3 by
immunoblot, as well as differentiation defects [10,27]. Thus, we
analyzed the pattern of H3K27me3 enrichment by ChIP-Seq in
mutant and wild-type ESCs to determine chromatin enrichment
for this mark across the genome. Close inspection of biological
replicates showed that while H3K27me3 displayed lower average
levels at PRC2 target genes in Suz12GT ESCs, its pattern of
enrichment at TSSs is highly similar to wild-type ESCs
(Figure 1E–F and S1G–H). In contrast, H3K27me3 is largely
diminished across the genome in both Suz12D and Eednull ESCs.
Our observation that the Suz12GT ESCs display detectable
H3K27me3 levels suggests that at least a partially active PRC2
complex can function in these cells. To test whether we could
recover canonical PRC2 from mutant ESC lines, we first
confirmed the expression of the Suz12-b-gal fusion in ESCs by
X-gal staining (Figure 1B). We next immunoprecipitated PRC2
with an EED-specific antibody and resolved the complexes by
SDS-PAGE, followed by immunoblotting for EZH2. We observed
that EED interacted with EZH2 in the mutant ESCs, and that
EZH2 appeared slightly more stable in Suz12GT ESCs compared
to the Suz12D or Eednull lines, as shown by the less prominent
degradation product (Figure 1C, S1C–E). Prior studies have
indicated that EZH1, another H3K27-methyltransferase, can
partially rescue loss of EZH2 in ESCs by forming an alternate
form of PRC2 [28,29]. Thus, we also tested the possibility that
H3K27me3 levels were maintained in Suz12GT ESCs through an
EZH1-PRC2 complex. Whereas H3K27me3 levels were further
diminished in Suz12GT ESCs upon shRNA-depletion of Ezh2,
Ezh1 suppression did not affect H3K27me3 levels at target genes,
as measured by ChIP-qPCR (Figure 1D and S1F). Collectively,
these data suggest that the Suz12GT allele functions as a
hypomorph in vitro and can be used as a tool to study the role
of PRC2 in lineage commitment.
H3K27me3 is necessary for lineage specification
Understanding the role of PRC2 during lineage commitment
has been a challenge because ESCs lacking H3K27me3 do not
properly differentiate. Thus, we investigated this question using
the various PRC2 mutant ESC lines described above. As a model
of lineage commitment, we performed directed differentiation of
ESCs to Spinal Motor Neurons (SMNs) by removal of LIF as well
as addition of retinoic acid and an agonist of the Sonic Hedgehog
signaling pathway [30] (Figure 2A). We found that genes normally
activated in differentiating SMNs (e.g. Pax6, Olig2, Isl1, andHb9)
were expressed in a similar temporal manner in Suz12GT cells
albeit at lower levels compared to wild-type cells (Figure 2B). In
contrast, these genes failed to properly activate in Suz12D or
Eednull cells. Consistent with these data, immunohistochemistry
showed that OLIG2, a PRC2 target and key transcription factor
that directs SMN differentiation, was detected in a proportion of
Suz12GT cells at day 5 of differentiation, but not in Suz12D cells
(Figure 2C). In agreement with previously reported results, we also
observed that the pluripotency marker Oct4 showed a delayed
repression in PRC2 mutant cells during differentiation compared
to wild-type cells [22] (Figure S2A). Thus, Suz12GT ESCs
maintain the ability to activate lineage programs, albeit less
efficiently than wild-type cells suggesting a critical role for
H3K27me3 in this process.
Bivalent genes in ESCs largely resolve to either an active
(H3K4me3 only) or repressed (H3K27me3 only) state during
differentiation [14]. In addition, PRC2 target genes tend to gain
large H3K27me3 domains at non-lineage genes during differen-
tiation [19]. Thus, we next tested how H3K27me3 levels in ESCs
can affect chromatin states in SMN differentiation. We observed
that about half of PRC2 target genes in ESCs showed higher
enrichment of H3K27me3 by day 5 of SMN differentiation in
wild-type cells (Figure 2D, E and S2C). Of the 1670 bivalent genes
that gained over 4-fold in H3K27me3 levels in wild-type cells
during differentiation, 836 (50%) also showed a concomitant
decrease greater than 1.5 fold in H3K4me3 levels. This is
consistent with the idea that a subset of bivalent genes resolves to a
more repressed state (Figure 2E, S2C left). Gene ontology (GO)
analysis indicated that genes that gained H3K27me3 function in
transcription, neuronal differentiation (e.g. genes of non-SMN
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lineages), pattern specification, and embryonic morphogenesis,
among other biological pathways important for proper lineage
specification (Table S4 in File S1). Of the 1226 genes that gained
1.5-fold H3K27me3 over differentiation in wild-type cells and
were also bivalent in Suz12GT, 79 also showed increase in
Suz12GT over differentiation, albeit at 2.56-fold reduced levels.
Notably, 63/79 (79.7%) also lost H3K4me3.1.5-fold, resolving
their bivalency in favor of H3K27me3. (Figure 2E and S2C right).
Additionally, we confirmed that the genes that gained the most
H3K27me3 in wild-type cells also showed an increase in Suz12GT
cells, albeit at considerably lower levels (Figure 2D). H3K27me3
enrichment in Suz12GT SMNs more closely paralleled the levels
Figure 1. Comparison of PRC2 mutant ESC lines. (A) At top, a diagram of the structure of the wild-type (wt) Suz12 gene. Below, the proteins
encoded by the two mutant alleles used here (SUZ12GT and SUZ12D) and the wt allele are shown to scale, and domains of interest are noted on wt
SUZ12. (B) X-gal staining was performed on wt ESCs (upper left) and Suz12GT ESCs (upper right) expressing either a scrambled control hairpin, a
hairpin targeted to LacZ (encoding b-galactosidase) (lower left), or a hairpin targeted to the 59 end of Suz12 (lower right). (C) Immunoprecipitation of
EED was performed in wt, Suz12GT, Suz12D, and Eednull ESCs. The samples, including 3% input, were subjected to SDS-PAGE. EZH2 immunoblot was
performed as indicated by the labeled band (left). EZH2 degradation product is marked by an asterisk (*). (D) ChIP-qPCR for H3K27me3 was
performed on wt and Suz12GT ESCs expressing hairpins: scr (scrambled control), Ezh2-kd (targeted to Ezh2), and Ezh1-kd (targeted to Ezh1). All genes
tested except Oct4 are PRC2 target genes. Error bars show standard deviation of three technical replicates. In (E) and (F), ChIP-seq for H3K27me3 was
performed on wt, Suz12GT, Suz12D, and Eednull ESCs. ChIP-seq datasets are normalized to the total mapped reads. (E) A metagene analysis of
H3K27me3 ChIP-seq enrichment is shown across the average of all PRC2 target genes +/2 2 kb relative to the TSS for wt, Suz12GT, Suz12D, and Eednull
ESCs, as well as input. (F) H3K27me3 ChIP-seq tracks in ESCs. Representative examples of PRC2 target promoters (Gata6 and Bmp2) showing
H3K27me3 levels in Suz12GT, Suz12D, and Eednull ESCs.
doi:10.1371/journal.pone.0110498.g001
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Figure 2. H3K27me3 levels show differences across SMN differentiation in Suz12GT cells compared to wt cells. (A) Cartoon showing
changes in marker expression across the spinal motor neuron (SMN) differentiation time course. (B) Heatmap of qRT-PCR analysis of genes from (A).
White: minimum expression; saturated color: maximum expression level observed for that gene. Expression for each of the five genes is shown, log2
transformed, for wild-type (wt) (top), Suz12GT (2nd), Suz12D (3rd), and Eednull (bottom) cells. The time course progresses from left to right for 7 days. (C)
PRC2 Regulates Lineage Fidelity during ESC Differentiation
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observed in wild-type ESCs whereas Suz12D or Eednull mutant
cells showed no H3K27me3 as expected (Figure 2D, F, S2B).
Bivalent PRC2 target genes that are needed during lineage
specification resolve their bivalency in favor of H3K4me3. Of the
368 bivalent genes that lost over 2-fold in H3K27me3 levels in
wild-type cells over differentiation, 138 (37.5%) also showed a
concomitant increase greater than 2-fold in H3K4me3 levels
(Figure 2E and S2C, left). GO analysis of genes losing H3K27me3
revealed enrichment for genes that have roles in cell adhesion (e.g.
cadherins and protocadherins), neuron differentiation (e.g. HoxA1,
HoxA2, Sox1), and axon guidance (e.g. Gap43, Sema6c),
consistent with the progressive activation of the SMN pathway
(Table S4 in File S1). Notably, of the 64/368 genes that lost 2-fold
H3K27me3 over differentiation in wild-type cells and were also
bivalent in Suz12GT, 49 also showed a decrease over differenti-
ation in Suz12GT, albeit at 2.3 fold reduced levels, and 36/79
(45.6%) also gained H3K4me3.2-fold, resolving their bivalency
in favor of H3K4me3 (Figure S2C, right). GO analysis revealed a
broad spectrum of functions for genes losing H3K27me3 over
differentiation in Suz12GT cells (Table S4 in File S1), suggesting
that additional pathways failed to be repressed in the mutant cells.
Together, these data suggest that in ESCs, PRC2 is critical for
establishing chromatin states that allow for proper lineage
specification.
H3K27me3 is necessary for lineage restriction and fidelity
While studies have shown that PRC2 target genes are de-
repressed in PRC2 mutant ESC lines, how changes in H3K27me3
levels impact gene expression during differentiation is largely
unknown. Thus, we performed RNA-Seq on Suz12GT, Suz12D,
Eednull, and wild-type ESCs and compared differences in
expression patterns with changes in H3K27me3 levels. As
expected, PRC2 target genes are expressed at a higher level in
Eednull (median= 1.44 fpkm; p,5E-7) and Suz12D ESCs (medi-
an = 1.14 fpkm; p,5E-5) that lack H3K27me3 compared to wild-
type ESCs (median= 0.75 fpkm) (Figure 3A). Expression of genes
in Suz12GT ESCs is more similar to wild-type, albeit slightly
higher (median= .83 fpkm; p,5E-2), consistent with the partial
maintenance of H3K27me3 in these cells. Differences in overall
gene expression between the mutant and wild-type cells were
largely due to altered regulation of PRC2 target genes, as
demonstrated by the similar changes observed when considering
all genes (Figure S3A). Notably, genes that displayed the most
significant loss of H3K27me3 in PRC2 mutants relative to wild-
type ESCs correlated with the highest increase in expression levels,
as shown by the regression line (Figure 3B; see also S3B for
alternative regression methods). These data strongly suggest that
H3K27me3 levels are proportional to PRC2 target gene
repression in ESCs.
We next analyzed how H3K27me3 levels impact gene
expression states during directed SMN differentiation. As expect-
ed, the expression profiles of Eednull and Suz12D cells did not show
global activation of the SMN gene expression program, consistent
with their inability to undergo directed differentiation (Figure 3C,
middle and bottom, and Figure S3C). This trend was also
observed when examining only PRC2 target genes (Figure S3D).
Suz12GT cells, however, showed overall global activation of
lineage-specific genes during differentiation, as shown by the
clustering of the data points around the x= y line in the upper
right corner of the plot. In contrast, many of the genes down-
regulated in wild-type cells failed to be properly repressed in
Suz12GT cells, as indicated by the regression line on the left-hand
side of the plot (Figure 3C, top panel and Figure S3C).
To more precisely quantify the relationship between changes in
H3K27 tri-methylation levels and expression of PRC2 target genes
during SMN differentiation, we binned all genes into quintiles
based on fold change in H3K27me3 levels over differentiation,
and the change in expression was plotted for the bottom
(Figure 3D, left) and top (Figure 3D, right) quintiles for each cell
type. In wild-type cells, the set of genes that gained the most
H3K27me3 over differentiation displayed the largest change in
expression, showing significantly lower expression than the other
quintiles of genes (Figure S3E). GO analysis indicated that target
genes in this category have roles in transcription regulation,
pattern specification, embryonic morphogenesis, neuronal differ-
entiation (e.g. genes of non-SMN neuronal lineages), and cell fate
commitment (Table S4 in File S1).
In contrast, the genes that gained some H3K27me3 in Suz12GT
cells failed to show a similar decrease in expression as compared to
wild-type cells during differentiation (Figure 3D, right). Specifi-
cally, these cells were unable to repress genes expressed in other
germ layers such as Sox17, Gata4, T, and Bmp4 that were
normally silenced during lineage commitment in wild-type cells
(Figure 3E, S3G). On the other hand, the top 20% of genes that
lose H3K27me3 over the course of differentiation in wild-type cells
showed a similar relative increase in expression in both wild-type
and Suz12GT cells (Figure S3F). This set of genes functions in cell
adhesion, regionalization, axon guidance, and neuron differenti-
ation including genes important for SMN differentiation and
function (Table S4 in File S1). Eednull and Suz12D cells showed no
strong directional change in expression in either of these quintiles,
in agreement with their failure to undergo proper directed
differentiation (Figure 3D). Thus, proper H3K27me3 levels are
necessary both for activation of lineage programs and for
maintenance of lineage fidelity by repressing inappropriate
developmental pathways.
PRC2 activity antagonizes DNA methylation in cis during
lineage commitment
Emerging evidence indicates that PRC2 functions with other
epigenetic modifiers to regulate differentiation. For example, a
recent study using meDIP-chip (ChIP for 5-methyl-cytosine
coupled with a promoter microarray) suggested that DNA
methylation levels were modestly affected in Eednull ESCs
compared to wild-type cells [18], however, this method measures
DNA methylation levels over hundreds of base pairs, making it
difficult to determine a direct relationship between these
complexes. Moreover, how these two pathways are coordinated
IHC for OLIG2 on paraffin-embedded sectioned day 5 SMNs. OLIG2 expression is shown as darkly stained cells. (D) ChIP-seq enrichment for
H3K27me3 is shown for wt, Suz12GT, Suz12D, and Eednull ESCs and corresponding day 5 differentiated cells. ChIP-seq datasets are represented as
metagene plots showing average reads per million within 2 kb of all TSSs for wt, Suz12GT, Suz12D, and Eednull cells. Day 0 (ESC) is at top, while day 5
SMN is shown at bottom. (E) H3K27me3 and H3K4me3 ChIP-seq tracks for Gata6 promoter (left); Bmp2 promoter (middle); and the HoxA cluster
(right) show that H3K27me3 levels change (increase, decrease, or stay the same, depending upon locus) in Suz12GT cells upon differentiation.
H3K4me3 levels change similarly in Suz12GT and wild-type cells over differentiation, but at lower levels in Suz12GT. (F) ChIP-qPCR data confirm that
Suz12GT cells are capable of gaining significant H3K27me3 at Lhx9 and Inhbb, the two genes that gain the most H3K27me3 over differentiation in wt
cells according to the ChIP-Seq data, whereas Eednull cells show no gain in H3K27me3 at these genes. Error bars represent standard deviation of three
technical replicates. P-values were calculated with a Student’s two-sided t-test. *: p,5E-10; **: p,5E-15.
doi:10.1371/journal.pone.0110498.g002
PRC2 Regulates Lineage Fidelity during ESC Differentiation
PLOS ONE | www.plosone.org 5 October 2014 | Volume 9 | Issue 10 | e110498
to regulate gene expression has not been examined during lineage
commitment. Thus, we performed reduced representation bisulfite
sequencing (RRBS) [31,32] during SMN differentiation as a
method to analyze DNA methylation at individual CpG sites
across the genome in wild-type and PRC2 mutant cells. While cell
lines lacking all H3K27me3 were slightly hypomethylated in
general, we did not observe dramatic changes in global DNA
methylation over differentiation in wild-type cells or in any of the
PRC2 mutant cells (Figure 4A). However, by focusing on
Figure 3. Proper H3K27me3 levels are necessary for coordinating developmental gene expression programs. (A) RNA-seq of wild-type
(wt), Suz12GT, Suz12D, and Eednull ESCs. Distributions of FPKMs of PRC2 target genes are shown as box and whisker plots that extend from the 25th to
75th percentile; whiskers represent 1.5x the length of the box. P-values were calculated with Student’s two-sided t-test. *: p,5E-2; **: p,5E-5; ***: p,
5E-7. (B) RNA-seq and H3K27me3 ChIP-seq are shown for Suz12GT (left panel), Suz12D (middle panel), and Eednull (right panel) ESCs with respect to wt.
Kernel densities of the data are represented along 14 levels. A segmented regression method was used to calculate localized best-fit and is plotted in
red. (C) RNA-seq of wt, Suz12GT, Suz12D, and Eednull ESCs and day 5 SMNs. y-axis shows log2 of the ratio of FPKM in differentiated: ESC in mutant lines
as indicated; x-axis represents this ratio in wt cells. Kernel densities of the data are represented along 14 levels. Segmented regression on the data is
plotted in red and the y = x line in orange. (D) Relationship between change in H3K27me3 and expression over differentiation is shown as box plots.
All genes were binned by change in H3K27me3 levels over differentiation in each respective cell type (log2 of H3K27me3 (day 5/day 0)). y-axis shows
distribution of change in expression (log2 of FPKM (day 5/day 0)). Left panel: bottom quintile in each cell type. Right panel: top quintile in each cell
type. P-values were calculated using a Student’s t-test and are represented by colored lines between bins. (E) Change in H3K27me3 and expression
over differentiation for representative genes. Gain or loss in H3K27me3 or expression is represented by upward or downward arrow, respectively,
whereas magnitude is represented by size of arrow.
doi:10.1371/journal.pone.0110498.g003
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individual CpG sites within PRC2 target regions, we detected
modest but significant changes in DNA methylation.
To further analyze the relationship between H3K27me3 and
DNA methylation, we limited our analysis to those CpGs with $
10x coverage and within H3K27me3-enriched regions defined in
Figure 4. PRC2 is antagonistic to DNA methylation in cis. Through RRBS, percent methylation at each CpG with $10-fold coverage was
calculated in wild-type (wt), Suz12GT, Suz12D, and Eednull ESCs and day 5 differentiated cells. (A) Distribution of methylation at all CpGs is shown. Low:
#15% methylated; high: $80%. (B) This panel is an explanatory example of the data analysis and visualizations used in Figures 4C–D, using the
lower-left heatmap of 4C as an example. (left) CpGs were binned according to % methylation in wt (y-axis) and Suz12GT (x-axis) ESCs. Thus, the matrix
displays the number of CpGs in each 2-D bin. The data is largely along the x = y line (CpGs with the same % methylation in Suz12GT as wild-type),
shifting towards the top right (more methylation in Suz12GT). (right) Fold enrichment over the overall distribution of the data was determined for
each bin using a replicate-based background model (see Methods). In this example, high statistical enrichment over background in Suz12GT cells
(yellow) is visible for CpGs with little methylation in wt cells (C) CpGs in wt H3K27me3-enriched regions are used to analyze changes in DNA
methylation in ESCs (left panel) and day 5 SMN (right panel). The enrichment in the lower heatmaps shows CpGs with low methylation in wt (y-axis)
gaining methylation in Suz12GT (x-axis). (D) (Top) H3K27me3-enriched regions in wt ESCs that lose enrichment in Suz12GT. (Bottom) Regions
maintaining H3K27me3 enrichment in Suz12GT ESCs. Regions losing H3K27me3 in Suz12GT cells gain overall more DNA methylation than those
maintaining significant H3K27me3.
doi:10.1371/journal.pone.0110498.g004
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wild-type cells in either ESC or day 5 SMNs. Figure 4B is a
diagram of the data analysis and visualization methods we used for
this comparison. In this example, first, each CpG was binned
according to its percent DNA methylation in wild-type ESCs on
the y-axis, and according to its percent DNA methylation in
Suz12GT ESCs on the x-axis (Figure 4B, left). The results can be
displayed as a heatmap showing the number of CpGs in each 2-D
bin. Fold enrichment relative to a background model was then
determined for each bin (see Methods) (Figure 4B, right). Overall,
we found that CpG sites within H3K27me3-enriched regions
showed very low levels of DNA methylation. However, in ESCs
and at day 5 of SMN differentiation, PRC2 mutants displayed a
significantly larger-than-expected number of CpGs with increased
levels of DNA methylation compared to wild-type cells (p,5E-7),
as shown by the signal at the top-right corner of the bottom two
heatmaps in Figure 4C (depicting Suz12GT) and Figure S4. We
also found that CpG sites that are within regions that lose
H3K27me3 in Suz12GT ESCs or day 5 SMNs gained more DNA
methylation compared to regions that maintained H3K27me3 in
these cells (Figure 4D). These results indicate that PRC2 (or
H3K27me3) directly antagonizes DNA methylation, and loss of
the mark allows increased DNA methylation.
Modest increase in DNA methylation in PRC2 mutants
does not affect gene expression
We next wanted to test the consequence of the increase in DNA
methylation on expression of PRC2 target genes in Suz12GT cells.
To address this question, CpG dinucleotides in regions losing
H3K27me3 enrichment in Suz12GT cells were first assigned to a
gene based on distance and position relative to the nearest
transcription start site (see Methods). We then determined the
change in expression at those genes compared to wild-type cells
using our RNA-seq data. In ESCs, about 25% of CpG sites in
H3K27me3-depleted regions gained $10% methylation in
Suz12GT ESCs, and mapped to genes including Bmp2, Gata3,
and Fgf8, as well as a number of homeobox genes. In day 5
SMNs, about 18% of CpG sites in H3K27me3-depleted regions
gained $10% DNA methylation in Suz12GT cells, and are
associated with genes such as En1 and Wnt6. We also observed
that a smaller proportion of CpG sites displayed a $10% decrease
in DNA methylation within these regions. While we observed a
trend toward an overall increase in DNA methylation at CpG sites
within PRC2 target regions, individual CpGs in proximity to a
given gene can either gain or lose DNA methylation in Suz12GT
cells suggesting that changes in DNA methylation are stochastic.
By comparison of RNA-Seq data sets in wild-type and Suz12GT
ESCs or day 5 differentiated cells, we did not observe a significant
change in expression for genes that showed either an overall
modest increase or decrease in DNA methylation at these sites
(Figure 5A–B). Figure 5C shows representative examples of PRC2
target genes and their observed changes in H3K27me3, DNA
methylation, and gene expression in Suz12GT cells. For example,
we observed overall loss of H3K27me3, gain of DNA methylation,
and increased expression of Gata3 and Bmp2 in Suz12GT ESCs
and over the differentiation time course compared to wild-type
cells. Notably, the observed derepression at PRC2 target genes in
Suz12GT cells is similar in magnitude to genes that do not display
changes in DNA methylation, suggesting that the modest increase
in DNA methylation does not suppress the effects of loss of PRC2
activity. Collectively, our data suggest that PRC2 plays a role in
preventing inappropriate DNA methylation at lineage-specific
genes and that developmental promoters are largely regulated by
PRC2 activity during lineage commitment.
Discussion
Regulation of PRC2 activity is essential to mammalian
development and differentiation. Loss of PRC2 and its catalyzed
mark, H3K27me3, leads to lethality during gastrulation, a period
of development when complex gene expression patterns are
established in the embryo [4,6,27]. While studies have shown that
PRC2 silences developmental programs in ESCs, its roles during
differentiation and lineage commitment have not been extensively
studied due to the inability of PRC2 mutant ESCs to properly
differentiate. In order to gain new insights, we exploited a mutant
genetrap allele of Suz12 that acts as a hypomorph in vitro in that
it maintains partial H3K27me3 levels and allows for low-efficiency
directed differentiation of ESCs to SMNs. We show that the
proper lineage programs can be activated during differentiation,
however, genes that normally gain H3K27me3 over differentiation
and become repressed in wild-type cells failed to be fully repressed
in Suz12GT cells. Comparatively, Eednull and Suz12D ESCs lack
H3K27me3 and fail to properly induce differentiation programs.
These data provide strong evidence that regulation of proper
H3K27me3 levels is necessary for lineage commitment.
H3K4me3 and H3K27me3 co-occur at the promoters of a large
cohort of developmental regulators in ESCs [14]. These ‘‘biva-
lent’’ promoters are thought to poise genes for later activation
during lineage commitment. While bivalent domains largely
resolve to either active (H3K4me3 only) or repressed
(H3K27me3 only) during lineage commitment, current evidence
suggests that together the two histone marks are necessary to
coordinate temporal activation of lineage programs when signaled
to do so. For example, PRC2 is thought to be critical for repression
by inhibiting elongation or by preventing RNA Pol2 binding in
mammalian cells [33]. Upon activation, genes maintain
H3K4me3 and gain H3K36me3 marks which are poor substrates
for PRC2 [34–36]. Consistent with these observations, loss of
PRC2 (and H3K27me3) in ESCs has been shown to lead to de-
repression of target genes as well as a failure to activate lineage
pathways [9,10]. The correlation between a gain in H3K27me3
and the repression of non-lineage pathways supports a functional
role for H3K27me3 in mediating lineage fidelity. Consistent with
this idea, we find that while lower H3K27me3 levels in Suz12GT
ESCs allow for proper temporal activation of lineage genes, these
cells failed to accumulate larger H3K27me3 domains sufficient to
repress non-lineage genes. Together, these data indicate that
PRC2 is necessary for both the proper induction of lineage
programs and for repression of alternate pathways to restrict cell
fate.
CpG dinucleotides at the promoters of developmental genes,
which often reside in CpG islands, are primarily unmethylated in
the genome. While transcription factor binding appears to be a
major mechanism for preventing DNA methylation, our data also
support a role for PRC2 in antagonizing DNA methylation during
lineage commitment. Consistent with this idea, accumulating
evidence indicates that repression of developmental genes is largely
regulated by H3K27 methylation and not DNA methylation [37].
Our findings that Suz12GT ESCs can differentiate, albeit less
efficiently, and that these cells harbor regions of variable
H3K27me3 levels compared to wild-type cells, make them an
important tool to investigate this relationship. Using RRBS, we
show that in Suz12GT ESCs, PRC2 targets losing H3K27me3 with
respect to wild-type cells were more likely to gain DNA
methylation at CpG sites in these regions compared to regions
that maintained H3K27me3 levels, providing the first direct
evidence that PRC2 activity is directly antagonistic to DNA
methylation in cis.
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What targets a gene for permanent repression or activation?
PRC2 has recently been shown to recruit TET1, a dioxygenase
that converts 5-methyl-cytosine into 5-hydroxymethyl-cytosine,
which may safeguard developmental genes against inappropriate
DNA methylation [38]. Tet1 knockout animals display epigenetic
abnormalities, but its loss does not impact embryonic or postnatal
survival [39], suggesting that other family members (e.g. TET2
and TET3) or mechanisms also contribute to regulating DNA
methylation levels at PRC2 target genes. Additionally, a recent
study showed that PRC2 recruits DNMT3L, a catalytically
inactive DNA methyltransferase that sterically competes with
active DNA methyltransferases to prevent DNA methylation at
PRC2 target sites [17]. It is possible that loss of PRC2 activity in
Suz12GT cells prevents localization of TET family members or
Figure 5. Increased DNA methylation upon loss of PRC2 does not lead to target gene repression. (A) Regions with significantly enriched
H3K27me3 in wild-type (wt) ESCs were considered. All CpGs in these regions with 10x coverage via RRBS in both wt and Suz12GT ESCs, and$.1 FPKM
in at least one of these cell types, were used in the analysis. Of these 257 CpGs, 41 lose$10% DNA methylation, 75 gain$10% DNA methylation, and
141 do not change. The distribution of change in expression in Suz12GT ESCs with respect to wt ESCs of the genes associated with these CpGs is
plotted on the y-axis. No association between change in DNA methylation and gene expression is observed. (B) Same as in (A) except in day 5 SMNs.
Of these 15993 CpGs, 767 lose $10% DNA methylation, 2816 gain $10% DNA methylation, and 12410 do not change. The distribution of change in
expression in Suz12GT cells with respect to wt cells of the genes associated with these CpGs is plotted on the y-axis. No association between change in
DNA methylation and gene expression is observed. (C) Two example genes, Gata3 and Bmp2, are shown here. Change in H3K27me3 signal between
wt and Suz12GT cells is plotted on the left y-axis; gain in Suz12GT is shown in yellow, and loss is shown in blue. Change in DNA methylation for each
CpG with 10x coverage in both cell types is plotted in maroon on the right y-axis. Change in gene expression (log2 of the ratio of the FPKMs (Suz12
GT/
wt)) is shown in horizontal bar graphs to the right of the panel.
doi:10.1371/journal.pone.0110498.g005
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DNMT3L to promoters, leading to inappropriate DNA methyl-
ation. Each of these mechanisms could be critical for safe-guarding
developmental genes from an increase in DNA methylation that
could ultimately lead to hyper-methylation and to aberrant gene
expression patterns [37]. Our data show that while loss of PRC2
leads to an increase in promoter DNA methylation at target genes,
the modest increase is not sufficient to effect large changes in gene
expression. The low level of DNA methylation observed at the
genes that show decreased H327me3 may interfere with the
proper activation developmental pathways or may lead to
epigenetic instability in differentiated cell types. Consistent with
the latter idea, a low level of seeding of DNA methylation can lead
to an accumulation of this modification over time [37].
In addition to its roles in development, faulty regulation of PcG
proteins has been strongly correlated with the progression and
severity of cancer. In many different types of cancer, PcG proteins,
such as EZH2, are expressed at higher than normal levels, which is
thought to lead to aberrant silencing of tumor suppressor genes
[40–43]. Indeed, forced overexpression of Ezh2 leads to cancer
phenotypes [44], and inhibition of EZH2 is a promising cancer
therapy [45,46]. Conversely, decreased expression of PcG proteins
has also been observed in tumor samples, such as the downreg-
ulation of Bmi1 in melanoma [47], suggesting that loss of
Polycomb complexes leads to activation of oncogenes. Emerging
evidence also indicates that perturbation of PcG proteins in cancer
may have consequences on DNA methylation patterns. For
example, PRC2 target genes in ESCs are more likely to show
promoter DNA hypermethylation in cancer cells, suggesting that
H2K27me3 marks genes that become targets for more permanent
silencing [48–51]. These studies suggest that loss of PRC2 activity
can ultimately lead to epigenetic instability and loss of cell identity
during tumorigenesis. Thus, additional studies to investigate the
diverse mechanisms that PcG proteins employ to regulate cell fate
transitions and cell identity are critical to further our understand-
ing of both normal and pathologic development, and to facilitate
the design of relevant therapies.
Conclusions
Loss of H3K27me3 at gene promoters in ESCs leads to gene
derepression in ESCs (Figure 6A), and an inability to properly
activate developmental gene programs when signaled to do so
(Figure 6B). We find that an inability to gain H3K27me3 over
differentiation leads to failure to properly repress non-lineage
programs, leading to defects in lineage restriction and cell fate
(Figure 6C). We also show that PRC2/H3K27me3 is directly
antagonistic to DNA methylation in cis. While loss of PRC2 does
not lead to robust DNA methylation and repression of target genes
(Figure 6D), we propose that the low level seeding of inappropriate
DNA methylation may lead to further epigenetic instability in
differentiated cells, which may explain the molecular underpin-
nings of PRC2 disruption in cancer. Our work provides novel
insights into the role of PRC2 in mammalian development, and its
effect on gene expression during lineage commitment.
Materials and Methods
ESC culture
ESCs were cultured on irradiated MEFs under standard ESC
conditions. This includes E14 and Suz12GT (ola/129 background),
obtained from the Helin lab [22]; Suz12D (C57/BL6 background),
obtained from the Koseki lab [10]; and Eednull (BALB/cR1
background) [24], obtained from the Magnuson lab. ESCs were
collected by trypsinization, incubation on cell a culture plate for
20 minutes to remove MEFs, and collection of the ESCs in
suspension.
Spinal Motor Neuron differentiation
SMN differentiation was performed as described [52]. Cells
were collected at day 5, before the terminal differentiation stage,
and trypsinized to single-cell suspension for use in other assays.
RNA-seq
RNA was isolated using Trizol according to manufacturer’s
instructions, including optional step in protocol. RNA quality was
determined by Agilent Bioanalyzer. RNA-seq libraries were
prepared as in [53]. A final round of size selection by Agencourt
AMPure XP beads was performed to remove small fragments such
as primers. Sequencing was run on either an Illumina GA-2 or Hi-
Seq. For analysis, Bowtie v. 0.12.7, Tophat v1.3.2 and Cufflinks v
1.2.1 and Cuffdiff were utilized to determine the expression levels
of genes [54], using a NCBIN37, ENSEMBL-based annotation
and flags -p 4, -r 170, –segment-length 20 –segment-mismatches
1–solexa1.3-quals –no-novel-juncs. Cufflinks was guided using the
same annotation as Tophat with flags -b -u -p 6.
Contour plots and regression
Two-dimensional kernel density estimates (Figures 3B–C) were
computed from bivariate data (typically E14 wt versus a mutant
cell line) using the kde2d function from MASS library in the R
statistical environment (v.3.02), with 50 grid points in each
direction, and 14 levels were visualized. For regression analysis,
gene expression or read coverage fold-changes were log2-
transformed, and dependent variables were regressed using a
generalized linear modelling framework (glm, with an identity link
function) in the R statistical environment (v. 3.0.2). Segmented
regression was performed on the resulting object using the
‘‘segmented’’ R package (v. 0.3–3.0), with a starting psi parameter
(i.e. inflexion point) set at 20.5 for all analyses For comparison,
locally-weighted regression (loess) was also performed using the
stat package.
ChIP-seq
Chromatin immunoprecipitation (ChIP) was performed based
on the protocol as described in Lee et al., 2006 [55], with
modifications and adaptations. Briefly, a Diagenode bioruptor was
used for sonication of formaldehyde-crosslinked cells on high for
30 s on/30 s off for 45 cycles in sonication buffer (20 mM Tris-
HCl; 150 mM NaCl; 2 mM EDTA; 0.1 mM SDS; 1% Triton X-
100; protease inhibitor (Thermo-scientific)). In ChIPs to be
sequenced, the Diagenode IP-star was also used for automation
of the ChIP protocol, according to the manufacturer’s specifica-
tions. Antibodies used for ChIP are listed in Table S1 in File S1.
After purification of DNA, samples were used for quantification
via qPCR and/or used to prepare libraries for Illumina
sequencing. Library preparation is performed essentially as
described in Schmidt et al., 2009; the amplification and size
selection steps are reversed in order, and size selection was
performed using Agencourt Ampure XP beads [56]. Sequencing
was run on an Illumina Hi-Seq (barcoded). Peak calling was
performed as previously described [53]. All ChIPs described in this
paper are listed in Table S3 in File S1.
X-gal staining
Cells grown on cell culture plates were fixed for 4 minutes in
fixing solution (4% formaldehyde, 0.5% glutaraldehyde, 0.1 M
NaH2PO4, 0.1 M Na2HPO4), rinsed twice with PBS, and stained
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at 37uC until sufficiently colored, in staining solution (1 mg/mL
X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6N3H2O, 2 mM
MgCl2, 1xPBS).
Immunoprecipitations
Protein G Dynabeads (Life Technologies) were added to the
appropriate antibody and incubated in PBS + BSA for 4 hours at
4uC. Concomitantly, cells were incubated in lysis buffer (50 mM
hepes pH 7.2, 250 mM NaCl, 10% (vol/vol) glycerol, 2 mM
EDTA, 0.1% (vol/vol) Nonidet P-40, protease inhibitor (Thermo-
scientific)) [57] for 20 minutes on ice. In the middle of this lysis,
the cells were briefly homogenized using a Tissue Tearor
homogenizer. This lysate was then spun down 5 minutes at
16,000 g at 4uC to remove debris, and the supernatant used as
input. 3% of the input was boiled 10 minutes in Laemmli buffer
and set aside at 220uC. The bead mixture was then added to the
input, and this rotated at 4uC for 4 hours. Beads were washed 3x
with lysis buffer, resuspended in Laemmli buffer, and boiled for
10 minutes before removal of beads and analysis of supernatant by
Western blot.
shRNA-mediated knockdown of transcripts in ESCs
Oligonucleotides were designed such that when annealed, they
would form dsDNA that would be transcribed into an RNA
hairpin. Annealed hairpin dsDNA was ligated into the pLKO.1
vector. This construct was then co-transfected with packaging
vectors into 293 cells, and the virus produced was filtered and used
Figure 6. PRC2 plays roles in gene regulation both in pluripotency and during lineage commitment. (A) In ESCs, PRC2 localizes largely
to developmental regulator genes, and maintains them in their repressed, and yet poised, state. (B) Proper H3K27me3 levels are necessary to activate
developmental gene programs during differentiation. (C) A gain in H3K27me3 during differentiation represses alternate-lineage genes, allowing for
efficient lineage restriction. (D) PRC2 antagonizes DNA methylation in cis, and may play a role in preventing the premature permanent repression of
developmental genes.
doi:10.1371/journal.pone.0110498.g006
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to infect ESCs. These infected cells were puromycin-selected
before testing the knockdown level by qRT-PCR.
Quantitative reverse transcriptase PCR
For expression analysis, RNA was extracted using Trizol
according to manufacturer’s instructions, and cDNA was made
using MMLV reverse transcriptase according to manufacturer’s
instructions, with random hexamer primers. Quantitative reverse
transcriptase PCR was performed on either cDNA or ChIP
template using a Roche LightCycler 480 machine, using KAPA
SYBR FAST Master Mix (2X) optimized for this machine.
Primers are listed in Table S2 in File S1. Reactions were prepared
in triplicate and temperature cycled according to the product
specifications. Analysis of data was performed by comparing each
reaction of the experimental triplicate to each reaction of the
control triplicate, using a 22dCp model [58]. The average and
standard deviation of this set of results was then calculated.
Immunohistochemistry
Aggregated motor neurons at day 5 of the Spinal Motor Neuron
differentiation were collected and fixed for 20 minutes in 10%
formalin, washed with PBS, and then dehydrated in sequentially
higher concentrations of ethanol for 20 minutes each (70%, 80%,
95%, 95%, 100%, 100%, 100%) and washed three times in
Xylene. They were then embedded in paraffin overnight at 60uC
and sectioned to 0.4 uM. Parafin was removed with xylene, and
the samples were rehydrated. Immunohistochemistry was per-
formed with anti-OLIG2 antibody (Table S2 in File S1) at 1:500.
RRBS
Reduced representation bisulfite sequencing was performed as
published [32] and sequenced on an Illumina Hi-Seq. The
sequencing data were analyzed initially as published. Briefly, reads
were mapped against an in-silico modified mouse genome (UCSC
mm9, with inferred MspI restriction and genome-wide conversion
of C to T and G to A) using maq (v 0.7.1–9) with the parameters -
D -s 0 -M c -e 100 C. Resulting bam files were sorted and indexed
with samtools (v.0.1.16, r963:234) and per-position read pileups
were obtained with mpileup using unmodified mm9 as a reference.
Following that, for each sample, per-base read coverage and
fraction of C or G-containing reads (depending on the read
mapping strand) were extracted and CpG sites were summed and
summarized using custom perl scripts. Genome-wide methylation
levels were assessed by tallying the fraction of methylation-
representative reads over read coverage in each sample for sites
with 10x or higher coverage. For pairwise sample comparisons,
sites meeting a 10x-read coverage in both samples were binned
according to their methylation levels in both samples and
displayed in matrix form. To assess relative over- or underrepre-
sentation of a given bin, expected counts per bin were estimated by
averaging pairwise replicate methylation matrices in all cell types
(background model). Deviations from the expected distribution are
therefore represented as the observed: expected ratios (fold
enrichment). All DNA methylation values were floored at 0.01%
to allow calculations for CpGs with no methylation. Association of
a CpG with a gene was determined by its proximity. Briefly, a
CpG located within 4 kb of a gene body was associated with that
gene. Proximity to another gene-associated CpG was also used as
an alternate criterion. Otherwise, it was assigned to the nearest
PRC2 target gene within 200 kb.
All relevant data sets have been deposited at the NCBI Gene
Expression Omnibus, under accession number GSE53508.
Supporting Information
Figure S1 The Suz12GT allele produces a truncation-
fusion protein that interacts with canonical PRC2
components to form a partially functional complex. (A)
RNA-seq data shows the expected Suz12 mRNA in Suz12GT,
Suz12D, and wild-type (wt) ESCs. (B) Cell lysates from wt,
Suz12GT, Suz12D, and Eednull ESCs were subjected to SDS-
PAGE and western blotting with an antibody recognizing the C-
terminal region of SUZ12. b-actin is included as a loading control.
(C) The entire immunoblot shown cropped in Figure 1C. (D)
The immunoblot shown in Figure 1C/S1C was quantified using
QuantityOne software. Amount of EZH2 detected was normal-
ized to the amount in the wild-type 3% input sample. (E) The
degraded EZH2 (marked as *) in the immunoblot shown in
Figure 1C was quantified using QuantityOne software and plotted
normalized to the highest amount. (F) qRT-PCR was used to
measure the depletion of Ezh2 (top panel), and Ezh1 (bottom
panel) with respect to Suz12GT ESCs expressing a scrambled
control hairpin. Error bars represent the standard deviation of
three technical replicates. (G) Three distinct H3K27me3 ChIP-
seq experiments on Suz12GT ESCs show a similar localization
pattern with respect to wt ESCs and Eednull ESCs, as shown here
at representative PRC2 target gene Bmp2. (H) ChIP-seq signal is
shown in density plots at the TSS +/22 kb. Each horizontal line is
one PRC2 target gene. Reads per million in 50 bp bins is
represented on a white to black scale, with black being the 95th
percentile value. Genes were sorted with respect to wt H3K27me3
signal.
(TIF)
Figure S2 Suz12GT cells maintain some H3K27me3 at
PRC2 target genes upon differentiation. (A) RNA-seq
FPKM values for Pou5f1 (Oct4) are plotted for wt, Suz12GT,
Suz12D, and Eednull ESCs and day 5 SMNs. (B) Metagene
analysis of H3K27me3 ChIP-seq data in day 5 SMNs. Only PRC2
target genes are included in the analysis. Alternate representation
of the bottom panel of Figure 2D with a smaller-scale y-axis is
included to permit visualization of the differences between the
three PRC2 mutant cell lines. (C) For all genes that are bivalent
(H3K27me3+/H3K4me3+) in either ESCs or differentiated cells
for the relevant cell type, log2-transformed fold-changes of
H3K27me3 and H3K4me3 levels in TSS regions between D0
(ESCs) and D5 (SMN-lineage differentiated), respectively, are
depicted in WT (left) and Suz12GT (right) cells. Genes that
displayed a fourfold or greater increase H3K27me3 levels in WT
cells are highlighted in red in both panels, while genes with a 1.5-
fold drop in H3K27me3 levels and 1.5 fold or greater increase in
H3K4me3 levels in WT are highlighted in blue.
(TIF)
Figure S3 Suz12GT ESCs show diminished capacity to
repress alternate lineage genes during lineage commit-
ment. (A) RNA-seq was performed on wild-type (wt), Suz12GT,
Suz12D, and Eednull ESCs. The distribution of the fpkms of all
genes are plotted here; the median is indicated and labeled for
each cell type. The box extends through the InterQuartile Region
(IQR): the 25th to 75th percentile. The whiskers represent 1.5x the
length of the IQR. (B) RNA-seq and H3K27me3 ChIP-seq are
shown for Suz12GT (left panel), Suz12D (middle panel), and Eednull
(right panel) ESCs with respect to wt. Kernel densities of the data
are represented as contour plots along 14 levels. Three regression
methods were used to calculate localized best-fit, and are included
for comparison. Simple linear regression is in red, loess is in green,
and segmented regression (as in Figure 3B) in blue. The y= x line
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is in yellow. (C) Transcriptome analysis of wt, Suz12GT, Suz12D,
and Eednull ESCs and day 5 SMNs using RNA-Seq. y-axis shows
log2 of the ratio of FPKM in differentiated: ESC in mutant lines as
indicated; x-axis represents this ratio in wt cells. Contour plots and
regressions were generated as in S3B. (D) RNA-seq was
performed on wt, Suz12GT, Suz12D, and Eednull ESCs and day
5 MNs. Only wt ESC PRC2 target genes are shown here to
visualize how the expression of this set of genes changes over
differentiation in PRC2 mutant versus wt cells. The y-axis of each
panel shows the log2 of the ratio of the FPKM in differentiated vs.
ESC in the respective mutant line; the x-axis shows the same value
in the wt line. The y= x line is also plotted in orange for visual
reference. As a large number of genes are represented here, data
points were rendered transparent such that the density of points
plotted in one place can be approximated by the opacity of the
signal. (E) Relationship between change in H3K27me3 and
expression over differentiation in wild-type cells is shown as box
plots. All genes were binned by change in H3K27me3 levels over
differentiation (log2 of H3K27me3 (day 5/day 0)). y-axis shows
distribution of change in expression (log2 of FPKM (day 5/day 0)).
(F) Gene list from wt quintiles (in part E) (shown here in gray) was
used to generate box plots with Suz12GT expression data (shown in
violet). The two cell types were superimposed to demonstrate their
differences and similarities. (G) Example genes that show changes
in expression and H3K27me3 levels over SMN differentiation in
wt and Suz12GT cells are depicted. Sox3 and Nes are expressed in
neurectoderm. Sox17 and Gata4 are expressed in endoderm. T
and Bmp4 are expressed in mesoderm.
(TIF)
Figure S4 DNA methylation is gained at some PRC2
target sites in PRC2 null mutant ESCs. Data for Suz12D
and Eednull ESCs are shown here (goes with Figure 4C). CpGs
from regions enriched for H3K27me3 in wild-type (wt) ESCs are
used. CpGs are binned according to their % methylation in wt
ESCs on the y-axis and % DNA methylation in mutant ESCs on
the x-axis.
(TIF)
File S1 Excel workbook including four Supporting
Tables (Table S1–S4). Table S1. Antibodies. Table S2. Oligos.
Table S3. ChIPs. Table S4. Gene Ontology.
(XLSX)
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